20 likes | 107 Views
Explore the effectiveness of universal vs. preemptive anti-CMV strategies in reducing disease rates and organ complications. Learn from Kalil AC et al.'s study comparing various antiviral medications.
E N D
Percent reduction with the universal vs preemptive anti-CMV strategy relative to placebo or no therapy Kalil AC et al. Ann Intern Med 2005; 143:870-880.
Percent reduction in CMV organ disease vs controls with different antiviral medications Kalil AC et al. Ann Intern Med 2005; 143:870-880.